Problem

Secrecy about pharmaceutical products

Other Names:
Lack of public access to information on medicines
Incidence:

In the UK, it is a criminal offence for officials involved in the licensing or withdrawal of a drug to disclose any information about their decision. Although the manufacturers of drugs are required to produce data sheets that identify likely side-effects, there is no public right of access to these safety studies.

Related UN Sustainable Development Goals:
GOAL 12: Responsible Consumption and ProductionGOAL 17: Partnerships to achieve the Goal
Problem Type:
F: Fuzzy exceptional problems
Date of last update
18.03.2020 – 19:32 CET